Statins (e.g., Atorvastatin)

Treatment for Vascular Dementia

Typical Dosage: 10-80 mg daily (for Atorvastatin)

Effectiveness
72%
Safety Score
65%
Clinical Trials
200
Participants
60K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
10-80 mg daily (for Atorvastatin)
Time to Effect
Weeks-months for lipid reduction, long-term for vascular benefits
Treatment Duration
Lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
50(Treat 50 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
150(Treat 150 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$150
Side Effect Mgmt:$20
Total Annual:$220
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$20,000/QALY
QALYs Gained
0.15
Outcome-Based Costs
Cost per Responder
$489
Statins (e.g., Atorvastatin) Outcomes

for Vascular Dementia

Efficacy Outcomes
Overall Effectiveness
+72%
Response Rate
+45%
Common Side Effects
Myalgia (muscle pain)
+7%
GI upset
+3%
Liver enzyme elevation
+0.5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov